存在于A 型和 B 型转化体上的一种爱泼斯坦-巴尔病毒特异性细胞毒性 T 细胞表位。
An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants.
作者信息
Burrows S R, Misko I S, Sculley T B, Schmidt C, Moss D J
机构信息
Queensland Institute of Medical Research, Herston, Brisbane, Australia.
出版信息
J Virol. 1990 Aug;64(8):3974-6. doi: 10.1128/JVI.64.8.3974-3976.1990.
Abstract
In this report we describe a cytotoxic T-cell epitope in the Epstein-Barr virus nuclear antigen EBNA 6. This epitope is present on both A- and B-type transformants.
摘要
在本报告中，我们描述了爱泼斯坦-巴尔病毒核抗原EBNA 6中的一个细胞毒性T细胞表位。该表位存在于A型和B型转化体中。
相似文献
1
An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants.存在于A 型和 B 型转化体上的一种爱泼斯坦-巴尔病毒特异性细胞毒性 T 细胞表位。
J Virol. 1990 Aug;64(8):3974-6. doi: 10.1128/JVI.64.8.3974-3976.1990.
2
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).EB病毒核抗原3（EBNA 3）中的一种爱泼斯坦-巴尔病毒特异性细胞毒性T细胞表位。
J Exp Med. 1990 Jan 1;171(1):345-9. doi: 10.1084/jem.171.1.345.
3
Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.细胞毒性T淋巴细胞对A型爱泼斯坦-巴尔病毒转化体的识别定位在EBNA 3中的一个免疫显性表位上。
J Gen Virol. 1991 Feb;72 ( Pt 2):405-9. doi: 10.1099/0022-1317-72-2-405.
4
Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.利用重组痘苗病毒证明的针对爱泼斯坦-巴尔病毒核抗原的人细胞毒性T细胞反应。
Proc Natl Acad Sci U S A. 1990 Apr;87(8):2906-10. doi: 10.1073/pnas.87.8.2906.
5
Transformation-associated Epstein-Barr virus antigens as targets for immune attack.与转化相关的爱泼斯坦-巴尔病毒抗原作为免疫攻击的靶点。
Ann N Y Acad Sci. 1993 Aug 12;690:86-100. doi: 10.1111/j.1749-6632.1993.tb43999.x.
6
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.利用重组痘苗病毒定位爱泼斯坦-巴尔病毒细胞毒性T细胞表位：对疫苗开发的意义
J Exp Med. 1992 Jul 1;176(1):169-76. doi: 10.1084/jem.176.1.169.
7
Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.针对 Epstein-Barr 病毒（EBV）转化的 B 淋巴母细胞系产生的、受 I 类主要组织相容性复合体限制的细胞毒性 T 淋巴细胞。 这些细胞毒性 T 淋巴细胞对它们所针对的 EBV 转化的 B 淋巴母细胞系具有特异性。
J Exp Med. 1995 Jun 1;181(6):2221-8. doi: 10.1084/jem.181.6.2221.
8
Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.对表达病毒编码的潜伏膜蛋白LMP的转染细胞的爱泼斯坦-巴尔病毒特异性细胞毒性T细胞识别。
J Virol. 1988 Oct;62(10):3747-55. doi: 10.1128/JVI.62.10.3747-3755.1988.
9
Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.对核抗原3A中免疫显性的爱泼斯坦-巴尔病毒编码的细胞毒性T淋巴细胞表位无反应性：对疫苗策略的影响。
Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9478-82. doi: 10.1073/pnas.88.21.9478.
10
Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.在爱泼斯坦-巴尔病毒核抗原3中鉴定出五个新的细胞毒性T细胞表位。
J Gen Virol. 1994 Sep;75 ( Pt 9):2489-93. doi: 10.1099/0022-1317-75-9-2489.
引用本文的文献
1
Immunoinformatic Analysis Reveals Antigenic Heterogeneity of Epstein-Barr Virus Is Immune-Driven.免疫信息学分析揭示 EBV 免疫驱动的抗原异质性。
Front Immunol. 2021 Dec 16;12:796379. doi: 10.3389/fimmu.2021.796379. eCollection 2021.
2
HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.HLA-A*01:03、HLA-A*24:02、HLA-B*08:01、HLA-B*27:05、HLA-B*35:01、HLA-B*44:02 和 HLA-C*07:01 单链转基因/H-2 类 I 缺失小鼠：人类 T 细胞反应的新型多功能临床前模型。
J Immunol. 2013 Jul 15;191(2):583-93. doi: 10.4049/jimmunol.1300483. Epub 2013 Jun 17.
3
Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot".通过联合使用最佳表位矩阵、抗CD3单克隆抗体进行T细胞扩增以及“循环斑点法”同时评估针对多种病毒感染的细胞毒性T淋巴细胞反应。
J Transl Med. 2005 May 11;3(1):20. doi: 10.1186/1479-5876-3-20.
4
The immunology of Epstein-Barr virus infection.爱泼斯坦-巴尔病毒感染的免疫学
Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):475-88. doi: 10.1098/rstb.2000.0784.
5
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus.X连锁无丙种球蛋白血症患者不会感染爱泼斯坦-巴尔病毒：对该病毒生物学特性的启示
J Virol. 1999 Feb;73(2):1555-64. doi: 10.1128/JVI.73.2.1555-1564.1999.
6
Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.爱泼斯坦-巴尔病毒（EBV）的即刻早期反式激活因子Rta呈现出多个被EBV特异性细胞毒性T淋巴细胞识别的表位。
J Virol. 1998 Nov;72(11):8644-9. doi: 10.1128/JVI.72.11.8644-8649.1998.
7
Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.携带 HLA 等位基因不同亚型个体中 Epstein-Barr 病毒特异性细胞毒性 T 细胞反应的层次结构：对基于表位的抗病毒疫苗的意义。
J Virol. 1997 Oct;71(10):7429-35. doi: 10.1128/JVI.71.10.7429-7435.1997.
8
Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.对EB病毒的B型特异性和交叉反应性细胞毒性T淋巴细胞反应的鉴定。
J Virol. 1996 Dec;70(12):8858-64. doi: 10.1128/JVI.70.12.8858-8864.1996.
9
A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.一种表达爱泼斯坦-巴尔病毒（EBV）靶抗原的重组腺病毒能够在体外选择性地重新激活EBV细胞毒性T淋巴细胞记忆中的罕见成分。
J Virol. 1996 Apr;70(4):2394-402. doi: 10.1128/JVI.70.4.2394-2402.1996.
10
A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.
Immunogenetics. 1996;43(6):377-83. doi: 10.1007/BF02199806.
本文引用的文献
1
HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies.EB病毒特异性细胞毒性T细胞集落的HLA-DR抗原相关限制
Int J Cancer. 1984 Feb 15;33(2):239-43. doi: 10.1002/ijc.2910330212.
2
Long-term T-cell-mediated immunity to Epstein-Barr virus.针对爱泼斯坦-巴尔病毒的长期T细胞介导免疫
Cancer Res. 1981 Nov;41(11 Pt 1):4216-21.
3
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.爱泼斯坦－巴尔病毒DNA的U2区域可能编码爱泼斯坦－巴尔核抗原2。
Proc Natl Acad Sci U S A. 1984 Dec;81(23):7632-6. doi: 10.1073/pnas.81.23.7632.
4
T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A.T细胞介导的体外“自发性”及爱泼斯坦-巴尔病毒诱导的B细胞转化的消退：环孢菌素A的研究
Cell Immunol. 1984 Sep;87(2):646-58. doi: 10.1016/0008-8749(84)90032-7.
5
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.转化的狨猴白细胞释放传染性爱泼斯坦-巴尔病毒。
Proc Natl Acad Sci U S A. 1973 Jan;70(1):190-4. doi: 10.1073/pnas.70.1.190.
6
The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV.从成人和胎儿人类淋巴组织建立淋巴母细胞系及其对EB病毒的依赖性。
Int J Cancer. 1971 Nov 15;8(3):443-50. doi: 10.1002/ijc.2910080312.
7
Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells.在爱泼斯坦-巴尔病毒转化的细胞中表达四种病毒决定的核抗原。
Proc Natl Acad Sci U S A. 1986 Mar;83(5):1499-503. doi: 10.1073/pnas.83.5.1499.
8
Nature of polymorphism in HLA-A, -B, and -C molecules.HLA - A、-B和-C分子多态性的本质。
Proc Natl Acad Sci U S A. 1988 Jun;85(11):4005-9. doi: 10.1073/pnas.85.11.4005.
9
Geographical prevalence of two types of Epstein-Barr virus.
Virology. 1986 Oct 15;154(1):56-66. doi: 10.1016/0042-6822(86)90429-0.
10
A sixth Epstein-Barr virus nuclear protein (EBNA3B) is expressed in latently infected growth-transformed lymphocytes.第六种爱泼斯坦-巴尔病毒核蛋白（EBNA3B）在潜伏感染的生长转化淋巴细胞中表达。
J Virol. 1988 Jun;62(6):2173-8. doi: 10.1128/JVI.62.6.2173-2178.1988.
Zotero 插件